Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.
Accuray stock last closed at $2.21, up 0.91% from the previous day, and has decreased 25.59% in one year. It has underperformed other stocks in the Medical Devices industry by 0.09 percentage points. Accuray stock is currently +1.84% from its 52-week low of $2.17, and -48.59% from its 52-week high of $4.30.
As of Apr 18, 2024, there are 99.17M ARAY shares outstanding. The market cap of ARAY is $219.16M. In the last 24 hours, 693,508 ARAY shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy ARAY stock.
Based on our experience, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've selected the best brokerage, the next step is to fill out some personal details so you are able to buy ARAY today.
Now that you have filled out your info on our top ranked stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below for more details transferring money into your new investment account.
After you have selected the best place to buy Accuray stock, it's very important to evaluate their stock prior to buying, so you truly understand the risk as well as the opportunity.
WallStreetZen was created to help part-time investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARAY's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ARAY's true value.
Using relative valuations metrics:
You can do additional valuation analysis on ARAY's stock here.
Out of 1 Wall Street analysts who monitor ARAY, the consensus analyst rating on Accuray is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Accuray stock forecast page.
Last year, ARAY revenue was $447.48M. In the last 5 year, ARAY's revenue has gone up by 1.68% per year. This was slower than the Medical Devices industry average of 13.47%.
Learn more about ARAY's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at ARAY have sold more shares than they have bought.
Michael Hoge, Senior VP Global Operations of ARAY, was the latest ARAY insider to sell. They sold $31,056.69 worth of ARAY shares on Mar 1, 2024.
Dig into more about who owns ARAY stock here.
No, Accuray doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two main order types:
Click the Open Trade button and your broker will place the order.
If you need additional help buying stocks on eToro, click the helpful video below:
Now that you own some shares in ARAY, you'll want to keep up with your company.
Put ARAY on a watchlist to monitor your ARAY stock.
To reiterate, here are the 6 steps for buying Accuray stock:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Accuray, get started below.